AZ1495
AZ1495 is a potent and orally bioavailable small molecule inhibitor of IRAK4 (IC50=5 nM) and IRAK1 (IC50=23 nM) . It demonstrates research utility in models of diffuse large B-cell lymphoma, particularly for investigating oncogenic signaling driven by the MYD88L265P mutation in both cellular and in vivo studies.
Product Specifications
CAS Number
2196204-23-4
Product Name Alternative
Cancer, AZ1495, AZ-1495, AZ 1495, CLK4, CLK2, CLK1, diffuse large B-cell lymphoma (DLBCL), Inhibitor, haspin, Haspin Kinase, HaspinKinase, inhibit, IRAK4, IRAK, IRAK-1, IRAK1, IL-1R associated kinase, interleukin-1 receptor associated kinase 1 (IRAK1), interleukin-1 receptor associated kinase 4 (IRAK4), Interleukin-1 receptor associated kinase, weak base
Field of Research
Cell Biology, Immunology & Inflammation, Signal Transduction
Purity
98.36% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.59 mM) ; DMSO:10 mg/mL (25.94 mM)
Smiles
C1CC (CCO1) c1c[nH]c2ncnc (N[C@H]3CC[C@@H] (CC3) N3CCOCC3) c12
Molecular Formula
C21H31N5O2
Molecular Weight
385.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
